Japan Asset Strategy Leader, Immunology, R&D
, successful growth of AbbVie GK Ensures that the individual development assets add significant value to AbbVie GK, through effective...
, successful growth of AbbVie GK Ensures that the individual development assets add significant value to AbbVie GK, through effective...
, successful growth of AbbVie GK Ensures that the individual development assets add significant value to AbbVie GK, through effective...
partnership (i.e. Abbvie GK) and the development of the functional charters for the Japan form Medical Affairs perspective...
ã«ã¦ãƒ—ãƒãƒ€ã‚¯ãƒˆãƒ‡ã‚¶ã‚¤ãƒ³ã‹ã‚‰ãƒ‡ã‚£ãƒ¬ã‚¯ã‚·ãƒ§ãƒ³æ¥å‹™ã‚’担当ã—ã¦é ‚ãã¾ã™ã€‚ ■実績: ・DRiVE Xæè¼‰ãƒ¢ãƒ‡ãƒ«ãŒã€Œæ—¥æœ¬ãƒœãƒ¼ãƒˆãƒ»ã‚ªãƒ–・ザ・イヤー2023 å°åž‹è‰‡éƒ¨é–€ã€ã«é¸å®šã€‚https://www.gk-kyoto.com/topics/2031 ・地çƒç’°å¢ƒã«é…æ…®ã—ãŸæ–°ãŸãªä¾¡å€¤ã‚’デザインã§å‰µå‡ºï¼š 輸é€...機器分野ã«ãŠã„ã¦ä¸–界åˆã®CNFå¼·åŒ–ç´ æã‚’採用。環境対応ã¨CMFデザインã®ä¸¡ç«‹ã€‚https://www.gk-kyoto.com/topics/2003 ■詳細 å„クライアントã®å•†å“ä¼ç”»éƒ¨ã®å½¹è·è€…ã¨å…±ã«ä»Šå¾Œã®äº‹æ¥å±•é–‹ã‚’è¸ã¾ãˆãŸè°è«–ã‚’ã—ã€ãƒ¢ãƒŽ...
æ¦‚è¦ åŒç¤¾ã«ã¦ãƒ—ãƒãƒ€ã‚¯ãƒˆãƒ‡ã‚¶ã‚¤ãƒ³ã‹ã‚‰ãƒ‡ã‚£ãƒ¬ã‚¯ã‚·ãƒ§ãƒ³æ¥å‹™ã‚’担当ã—ã¦é ‚ãã¾ã™ã€‚ ■実績: ・DRiVE Xæè¼‰ãƒ¢ãƒ‡ãƒ«ãŒã€Œæ—¥æœ¬ãƒœãƒ¼ãƒˆãƒ»ã‚ªãƒ–・ザ・イヤー2023 å°åž‹è‰‡éƒ¨é–€ã€ã«é¸å®šã€‚https://www.gk-kyoto.com/topics.../2031 ・地çƒç’°å¢ƒã«é…æ…®ã—ãŸæ–°ãŸãªä¾¡å€¤ã‚’デザインã§å‰µå‡ºï¼š è¼¸é€æ©Ÿå™¨åˆ†é‡Žã«ãŠã„ã¦ä¸–界åˆã®CNFå¼·åŒ–ç´ æã‚’採用。環境対応ã¨CMFデザインã®ä¸¡ç«‹ã€‚https://www.gk-kyoto.com/topics/2003 ■詳細 å„ク...
[仕事詳細] â– æ¥å‹™æ¦‚è¦ åŒç¤¾ã«ã¦ãƒ—ãƒãƒ€ã‚¯ãƒˆãƒ‡ã‚¶ã‚¤ãƒ³ã‹ã‚‰ãƒ‡ã‚£ãƒ¬ã‚¯ã‚·ãƒ§ãƒ³æ¥å‹™ã‚’担当ã—ã¦é ‚ãã¾ã™ã€‚ ■実績: ・DRiVE Xæè¼‰ãƒ¢ãƒ‡ãƒ«ãŒã€Œæ—¥æœ¬ãƒœãƒ¼ãƒˆãƒ»ã‚ªãƒ–・ザ・イヤー2023 å°åž‹è‰‡éƒ¨é–€ã€ã«é¸å®šã€‚https://www.gk...-kyoto.com/topics/2031 ・地çƒç’°å¢ƒã«é…æ…®ã—ãŸæ–°ãŸãªä¾¡å€¤ã‚’デザインã§å‰µå‡ºï¼š è¼¸é€æ©Ÿå™¨åˆ†é‡Žã«ãŠã„ã¦ä¸–界åˆã®CNFå¼·åŒ–ç´ æã‚’採用。環境対応ã¨CMFデザインã®ä¸¡ç«‹ã€‚https://www.gk-kyoto.com/topics...
資管ç†çµŒé¨“ â– æ“迎 投資後BP作æˆã€äºˆå®Ÿï¼CFç®¡ç† è¤‡æ•°æ¡ˆä»¶ãƒ»SPC(GK-TKï¼‰ç®¡ç† å¤–éƒ¨èª¿æ•´ã€DD・クãƒãƒ¼ã‚¸ãƒ³ã‚°é–¢ä¸Ž 会計事務所ç‰ã§ã®å‹¤å‹™ã€æ—¥å•†ç°¿è¨˜2級以上 ä¼šè¨ˆãƒ»ç¨Žå‹™ãƒ»ãƒ•ã‚¡ã‚¤ãƒŠãƒ³ã‚¹åŸºç¤ŽçŸ¥è˜ â– ãã®ä»– æ•°å—ã«å¼·ãæ£ç¢ºã€ä¸å¯§...
産証券化案件・ファンド投資スã‚ームç‰ã®ã‚¢ãƒ¬ãƒ³ã‚¸ãƒ¡ãƒ³ãƒˆæ¥å‹™ã€ã‚¢ã‚»ãƒƒãƒˆãƒžãƒã‚¸ãƒ¡ãƒ³ãƒˆæ¥å‹™ã«æºã‚ã£ã¦ã„ãŸã ãã¾ã™ã€‚ ・信託å—益権スã‚ームã€GK-TKスã‚ームã€TMKスã‚ームを活用ã—ãŸä¸å‹•産売買ã€è¨¼åˆ¸åŒ–ã®ã‚¢ãƒ¬ãƒ³ã‚¸ãƒ¡ãƒ³ãƒˆã€ãƒ‰ã‚ュメン交渉 ・ノン...
計処ç†ã€æ±ºç®—対応ã€ã‚ャッシュフãƒãƒ¼ç®¡ç† ・投資実行後ã®ãƒ—ãƒã‚¸ã‚§ã‚¯ãƒˆã«ãŠã‘ã‚‹å„種対応 ãƒ»å®šä¾‹å ±å‘Šï¼ˆã‚ャッシュフãƒãƒ¼ï¼ç™ºé›»é‡ç‰ã®äºˆå®Ÿç®¡ç†ã€TK決算ã€GK決算ã€O&Mレãƒãƒ¼ãƒˆã€äº‹æ¥è¨ˆç”»æ›´æ–°ç‰ï¼‰çµŒé¨“ã«å¿œã˜ã¦ ・AMï¼ä¼šè¨ˆ...
案件・SPC(GK-TKï¼‰ç®¡ç† å¤–éƒ¨èª¿æ•´ã€DD・クãƒãƒ¼ã‚¸ãƒ³ã‚°é–¢ä¸Ž 会計事務所ç‰ã§ã®å‹¤å‹™ã€æ—¥å•†ç°¿è¨˜2級以上 ä¼šè¨ˆãƒ»ç¨Žå‹™ãƒ»ãƒ•ã‚¡ã‚¤ãƒŠãƒ³ã‚¹åŸºç¤ŽçŸ¥è˜ â– ãã®ä»– æ•°å—ã«å¼·ãæ£ç¢ºã€ä¸å¯§ã§å”調性ãŒã‚りã€ç¤¾å†…外ã¨å††æ»‘ã«ã‚³ãƒŸãƒ¥ãƒ‹ã‚±ãƒ¼ã‚·ãƒ§ãƒ³ãŒã¨ã‚Œã€å†ã‚¨ãƒæŠ•資ã«é–¢å¿ƒã®ã‚ã‚‹æ–¹...